Central hub supporting precision medicine for kidney disease
Central Hub for Kidney Precision Medicine
This project runs a central hub that helps teams collect kidney tissue, share data safely, and include patients so future care for people with kidney disease can be more personalized.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11400251 on NIH RePORTER |
What this research studies
The hub coordinates recruitment sites, tissue-analysis laboratories, and an Opportunity Pool to enable collaborative kidney research. It manages quality control for tissue and data, oversees ethical consent and participant safety, and supports patient engagement across the network. The hub partners with the Kidney Tissue Atlas Coordinating Center to make data Findable, Accessible, Interoperable, and Reusable. Its work is focused on creating a reliable, shared resource so researchers can study kidney disease more precisely.
Who could benefit from this research
Good fit: Ideal candidates are people with kidney disease (including acute kidney injury or other renal conditions) who are willing to allow collection of kidney tissue and share clinical data with the KPMP network.
Not a fit: People without kidney disease or those who are not willing to donate tissue or share their medical data are unlikely to participate or receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this hub could accelerate development of more personalized diagnoses and treatments by making high-quality kidney tissue and data widely available to researchers.
How similar studies have performed: This effort builds on earlier phases of the Kidney Precision Medicine Project that successfully established tissue and data resources, so it extends a proven approach rather than starting from scratch.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Himmelfarb, Jonathan — Icahn School of Medicine at Mount Sinai
- Study coordinator: Himmelfarb, Jonathan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.